Skip to content
DataLookout
Menu

NCT07145307

Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words
    • Primary completion pushed from Oct 2026 to Apr 2027
    • Study completion date: Mar 2027 to Apr 2027
    • Study description expanded, about 2 words
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Primary completion date: Sep 2026 to Oct 2026
    • Start date changed from estimate of Aug 2025 to Oct 20, 2025
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Sidekick app engagement and completion of tasks
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks)
Credibility and Expectancy Questionnaire (CEQ-1)
Timeframe: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)
Client Satisfaction Questionnaire (CSQ-3)
Timeframe: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)
EuroQoL 5D-5L (EQ-5D-5L)
Timeframe: At pre-treatment/baseline and post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)
Level of anxiety before, during and after exposure tasks
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks) after every completed exposure task (variable and participant-dependent, estimated range: 1-20 exposure tasks per month)
Recruitment
Timeframe: At pre-treatment/baseline.
Adherence
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and from post-treatment to 3-month follow-up.
Qualitative interviews
Timeframe: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline).
Revised Child Anxiety and Depression Scale (RCADS 47)
Timeframe: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.
General self-efficacy scale (GSES)
Timeframe: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.
KIDSCREEN-10
Timeframe: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.
Patient Exposure and Response Prevention Adherence Scale (PEAS)
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks) after every completed exposure task (variable and participant-dependent, estimated range: 1-20 exposure tasks per month)

Arms and interventions

SidekickExperimental

Use of the Sidekick app as an ad-on to regular outpatient treatment.

Devices: Sidekick

Sites

2 sites in 1 country